✦ LIBER ✦

Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta

✍ Scribed by Meganck, J.A.; Begun, D.L.; McElderry, J.D.; Swick, A.; Kozloff, K.M.; Goldstein, S.A.; Morris, M.D.; Marini, J.C.; Caird, M.S.

Book ID: 123531319
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 989 KB
Volume: 56
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2013.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sclerostin antibody improves skeletal pa

Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta

✍ Sinder, Benjamin P; Eddy, Mary M; Ominsky, Michael S; Caird, Michelle S; Marini, 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 766 KB

Sclerostin antibody improves skeletal pa

Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta

✍ Sinder, Benjamin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Comparable outcomes in fracture reductio

Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta

✍ R. Bargman; R. Posham; A. L. Boskey; E. DiCarlo; C. Raggio; N. Pleshko 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 893 KB

Nanoscale morphology of Type I collagen

Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta

✍ Joseph M. Wallace; Bradford G. Orr; Joan C. Marini; Mark M. Banaszak Holl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 949 KB

The effects of RANKL inhibition on fract

The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta

✍ Demetris Delos; Xu Yang; Benjamin F. Ricciardi; Elizabeth R. Myers; Mathias P.G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 387 KB 👁 1 views

## Abstract Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RAN

A Controlled Study of the Effects of Ale

A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta

✍ N.P. Camacho; C.L. Raggio; S.B. Doty; L. Root; V. Zraick; W.A. Ilg; T.R. Toledan 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 313 KB